Revenue
Cost
Profit
| Item | Category | Value | YoY |
|---|---|---|---|
| Sales | revenue | 24.57B | 2.90% |
| Gross profit | profit | 14.52B | 2.23% |
| Cost of product and service sold | cost | 10.04B | 3.89% |
| Interest income | revenue | 30.00M | -74.36% |
| Operating profit | profit | 4.69B | -3.56% |
| Selling, general and administrative expense | cost | 8.23B | 6.13% |
| Research and development expense | cost | 1.60B | 0.88% |
| Aggregate | revenue | 4.72B | -5.22% |
| Earnings from continuing operations before income taxes | profit | 4.23B | -8.89% |
| Interest expense, nonoperating | cost | 265.00M | -4.68% |
| Other income (expense), net | revenue | 222.00M | 296.43% |
| Earnings from discontinued operations, net of income taxes | revenue | 14.00M | |
| Net earnings from continuing operations | profit | 3.60B | -7.67% |
| Income tax provision | cost | 633.00M | -15.26% |
| Net earnings | profit | 3.61B | -7.31% |
| Net earnings attributable to common stockholders | profit | 3.61B | -7.31% |
| Segment | Value | YoY |
|---|---|---|
| Diagnostics | 9.94B | 1.57% |
| Life Sciences | 7.33B | 0.07% |
| Biotechnology | 7.29B | 7.90% |
| Segment | Value | YoY |
|---|---|---|
| North America | 10.36B | 0.59% |
| High-Growth Markets | 7.02B | 2.21% |
| Western Europe | 5.94B | 8.81% |
| Other Developed Markets | 1.25B | -0.08% |
| Segment | Value | YoY |
|---|---|---|
| Revenue from Contract with Customer, Measurement, Recurring | 20.13B | 3.93% |
| Revenue from Contract with Customer, Measurement, Nonrecurring | 4.44B | -1.51% |
| Item | Category | Value | YoY |
|---|---|---|---|
| Cash and equivalents | assets | 4.62B | 122.09% |
| Trade accounts receivable, less allowance for doubtful accounts of $114 as of december 31, 2025 and $113 as of december 31, 2024 | assets | 3.91B | 10.63% |
| Inventories | assets | 2.49B | 6.82% |
| Prepaid expenses and other current assets | assets | 1.74B | 12.05% |
| Total current assets | assets | 12.76B | 34.32% |
| Goodwill | assets | 43.15B | 6.55% |
| Other intangible assets, net | assets | 17.82B | -4.04% |
| Property, plant and equipment, net | assets | 5.53B | 10.84% |
| Other long-term assets | assets | 4.21B | 5.49% |
| Identifiable assets | assets | 83.46B | 7.64% |
| Total stockholders’ equity | liabilities | 52.54B | 6.04% |
| Long-term debt | liabilities | 18.42B | 18.81% |
| Total current liabilities | liabilities | 6.81B | 0.13% |
| Other long-term liabilities | liabilities | 5.70B | 0.11% |
| Noncontrolling interests | liabilities | 7.00M | 0.00% |
| Treasury stock, common, value | equity | 11.35B | 39.08% |
| Accumulated other comprehensive income (loss) | equity | 207.00M | -93.57% |
| Total danaher stockholders’ equity | equity | 52.53B | 6.04% |
| Accrued expenses and other liabilities | liabilities | 4.96B | 9.27% |
| Trade accounts payable | liabilities | 1.84B | 5.19% |
| Debt, current | liabilities | 2.00M | -99.60% |
| Aggregate | equity | 64.09B | 5.20% |
| Retained earnings (accumulated deficit) | equity | 46.89B | 6.12% |
| Additional paid in capital, common stock | equity | 17.19B | 2.79% |
| Common stock - $0.01 par value, 2.0 billion shares authorized; 886.9 million issued and 706.9 million outstanding as of december 31, 2025; 884.3 million issued and 719.1 million outstanding as of december 31, 2024 | equity | 9.00M | 0.00% |
| Item | Value |
|---|---|
| Total operating cash provided by continuing operations | 6.42B |
| Net earnings from continuing operations | 3.60B |
| Amortization of intangible assets | 1.70B |
| Depreciation | 750.00M |
| Impairment charges | 562.00M |
| Stock-based compensation expense | 298.00M |
| Investment (gains) losses, pretax gain on sale of product line and other | 228.00M |
| Change in accrued expenses and other liabilities | 41.00M |
| Change in trade accounts payable | 9.00M |
| Increase (decrease) in prepaid expense and other assets | -55.00M |
| Increase (decrease) in inventories | -58.00M |
| Increase (decrease) in accounts receivable | -216.00M |
| Increase (decrease) in deferred income taxes | -440.00M |
| Item | Value |
|---|---|
| Payment for (proceeds from) other investing activity | 33.00M |
| Proceeds from sales of property, plant and equipment | 33.00M |
| Proceeds from sales of investments | 12.00M |
| Proceeds from sales of investments | 9.00M |
| Payments for purchases of investments | -127.00M |
| Payments to acquire property, plant, and equipment | -1.16B |
| Total cash used in investing activities from continuing operations | -1.20B |
| Item | Value |
|---|---|
| Borrowings (maturities longer than 90 days) | 1.56B |
| Proceeds from the issuance of common stock in connection with stock-based compensation | 85.00M |
| Proceeds from (repayments of) short-term debt, maturing in three months or less | -11.00M |
| All other financing activities | -125.00M |
| Repayments of debt, maturing in more than three months | -500.00M |
| Payments of dividends | -878.00M |
| Net cash (used in) provided by financing activities for continuing operations | -2.96B |
| Payments for repurchase of common stock | -3.09B |
| Item | Value |
|---|---|
| Cash and cash equivalents, beginning of period | 2.08B |
| Cash and cash equivalents, end of period | 4.62B |
Instantly decode complex 10-K and 10-Q data. Explore interactive Sankey diagrams for income and balance sheets, and intuitive waterfall charts for cash flows.
Search for a company and select a report on the left panel.
Request Stock Support